These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 27544590)

  • 1. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
    Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
    Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
    Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
    Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.
    Rossi S; Castiglia D; Pisaneschi E; Diociaiuti A; Stracuzzi A; Cesario C; Mariani R; Floriddia G; Zambruno G; Boldrini R; Abeni D; Novelli A; Alaggio R; El Hachem M
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):1007-1016. PubMed ID: 33274474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
    Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
    Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
    Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
    Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
    J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
    Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
    Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
    Yuen WY; Jonkman MF
    J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
    Filoni A; Cicco G; Cazzato G; Bosco A; Lospalluti L; Tucci M; Cimmino A; Foti C; Marzullo A; Bonamonte D
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
    Rao R; Mellerio J; Bhogal BS; Groves R
    Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment].
    Chiaverini C; Bourrat E; Mazereeuw-Hautier J; Hadj-Rabia S; Bodemer C; Lacour JP
    Ann Dermatol Venereol; 2017 Jan; 144(1):6-35. PubMed ID: 27931749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
    Gayathri E; Anbukkarasi K; Lilly SM
    Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of skin cancers in epidermolysis bullosa.
    Venugopal SS; Murrell DF
    Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
    Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management and oncological follow-up of cutaneous squamous cell carcinomas arising in epidermolysis bullosa patients.
    Paganelli A; Giordano E; Fiorentini C; Ferrari B; Reggiani C; Garbarino F; Magnoni C
    Int J Dermatol; 2022 Oct; 61(10):1171-1174. PubMed ID: 35315931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
    Rami A; Łaczmański Ł; Jacków-Nowicka J; Jacków J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.